In this Issue
By Steven D. Vold, MD
By Rajendra K. Bansal, MD
Developing an understanding of this matricellular protein may reveal molecular targets for the therapeutic treatment of primary open-angle glaucoma.
By Ayan Chatterjee, MS; Dong-Jin Oh, PhD; Min Hyung Kang, PhD; Guadalupe Villarreal, MD; Ramez Haddadin, MD; Marc Töteberg-Harms, MD; Swarup S. Swaminathan, MD; and Douglas J. Rhee, MD
Ophthalmologists have an opportunity to advance health care.
By Eve J. Higginbotham, SM, MD
Glaucoma Today asked these experts to share their advice.
By Reay H. Brown, MD; Garry P. Condon, MD; Alan S. Crandall, MD; and Eric D. Donnenfeld, MD
By Eun S. Huh, MD, and Ahmad A. Aref, MD
cover stories: angle-closure glaucoma
A systematic approach can help you discriminate between forms of this disease.
By Douglas J. Rhee, MD
New concepts in the continuum of angle closure.
By Robert M. Feldman, MD, and Angelo P. Tanna, MD
It is incumbent on eye care providers to learn to recognize the risk factors.
By Simon K. Law, MD, PharmD
Pearls for managing a patient with glaucoma and a plateau iris configuration.
By Saya Nagori, MD, and Daniel Laroche, MD
Lens extraction or peripheral iridotomy?
By Nicholas P. Bell, MD, and Donna Nguyen, MD
Surgical intervention is challenging, and planning must take into account several factors.
By Marcos Reyes, MD
Early recognition and treatment of the cause promote resolution.
By Oluwatosin Smith, MD
Treating and managing this complication of ocular surgery.
By Jacob Brubaker, MD, and Steven R. Sarkisian Jr, MD
A common pathological mechanism explains the corneal, iris, and angle abnormalities that result in a rare but important type of secondary angle-closure glaucoma.
By Matthew D. Lazzara, MD, and Angelo P. Tanna, MD
By Nathan M. Radcliffe, MD
Dr. Fechtner makes a case for functional testing and divulges the secrets of brewing practically perfect espresso.